Titan Medical Inc (TMDIF)

[investinthefuture]

What could be interesting is the impact of the R/S on some of the warrants.

Let’s say they do a 30-1 at .25, resulting in a NASDAQ IPO at 7.50. They choose not to raise any capital at that time. The uplist results in larger investors being able to get in, creating demand that is largely non-existent now. Titan benefits from the same kind of speculation we’ve seen in other surgical robotic stocks.

The PPS runs past $15 (that’s .50 pre RS) on some well-timed news. This puts many of the more recent warrant tranches in the money, funding the company without further dilution (the warrants are already baked into the PPS now)

The thing that’s hurting the company right now isn’t technology or the will to succeed. What’s hurting it is limited access to the capital needed for a project of this size. Fix that, and we are back in business.